CoChat

Microengineered Multi‐Organoid System from hiPSCs to Recapitulate Human Liver‐Islet Axis in Normal and Type 2 Diabetes

Open access

The DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes mellitus (T2DM) is a systematic multi‐organ metabolic disease, which is characterized by the dynamic interplay among different organs. The increasing incidence of T2DM reflects an urgent need for the development of in vitro human‐relevant models for disease study and drug therapy. Here, a new microfluidic multi‐organoid system is developed that recapitulates the human liver‐pancreatic islet axis in normal and disease states. The system contains two compartmentalized regions connected by a microchannel network, enabling 3D co‐culture of human induced pluripotent stem cells (hiPSC)‐derived liver and islet organoids for up to 30 days under circulatory perfusion conditions. The co‐cultured liver and islet organoids exhibit favorable growth and improved tissue‐specific functions. Transcriptional analyses reveal the activation of metabolically relevant signaling pathways in the co‐cultured organoids. Notably, the co‐culture system facilitates sensitive glucose‐stimulated insulin secretion from islet organoids and increased glucose utilization in liver organoids by glucose tolerance tests. Both liver and islet organoids display mitochondrial dysfunction and decreased glucose transport capacity under high glucose conditions, which can be alleviated by metformin treatment. This novel multi‐organoid system can recapitulate human‐relevant liver‐islet axis under both physiological and pathological conditions, providing a unique platform for future T2DM research and drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202103495

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic of hiPSCs derived multi‐organoid‐on‐chip system to model human liver‐pancreatic islet axis in vitro. A) Simplified illustration of the crosstalk between human liver and islet tissues during normal glucose regulation in vivo. B) Procedures of the differentiation and generation of hiPSCs derived liver and islet organoids in the micro‐well device and co‐culture experimental set‐up in the multi‐organoid chip. The device consists of two culture compartments connected by parallel network to support the co‐culture of two types of organoids. C) Experimental setup of the microfluidic perfusion system and the real chip. D) Functional analysis of the liver‐islet organoids system was carried out using several experimental methods.
Figure 1 Schematic of hiPSCs derived multi‐organoid‐on‐chip system to model human liver‐pancreatic islet axis in vitro. A) Simplified illustration of the crosstalk between human liver and islet tissues during normal glucose regulation in vivo. B) Procedures of the differentiation and generation of hiPSCs derived liver and islet organoids in the micro‐well device and co‐culture experimental set‐up in the multi‐organoid chip. The device consists of two culture compartments connected by parallel network to support the co‐culture of two types of organoids. C) Experimental setup of the microfluidic perfusion system and the real chip. D) Functional analysis of the liver‐islet organoids system was carried out using several experimental methods.CC BY · PubMed Central
Figure 2 Identification of organ‐specific protein and gene expressions in liver and islet organoids prior to co‐culture assay. A) Timeline illustrating the differentiation process for liver and islet organoids from hiPSCs. DE, definitive endoderm; HP, hepatic progenitor; HC hepatocyte; PE, pancreatic endoderm; EP, endocrine progenitor; EC, endocrine cell. B) Immunohistochemical staining of hepatic‐specific proteins in liver organoids at day 20, including cytochrome P450 (CYP3A4), hepatocyte (ALB), and cholangiocyte (CK7). Quantification of relative mRNA expression levels of CYP3A4, ALB, and CK7 genes in liver organoids using RT‐PCR. C) The expression of pancreatic‐lineage markers for β‐cells (INS), α‐cells (GCG), γ‐cells (PPY), and δ‐cells (SST) in islet organoids at day 23 were determined by immunofluorescence staining. Quantification of relative mRNA expression levels of INS, GCG, PPY, and SST genes in islet organoids using RT‐PCR. Nuclei were stained with DAPI (blue). Scale bars: 100 µm. Enlarged images indicated by the white squares are shown on the right. Scale bars: 20 µm. Expression values were normalized to GAPDH. Relative expression is represented as the mean ± SEM, three independent experiments were performed. The data were analyzed using Student's t‐test, *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 2 Identification of organ‐specific protein and gene expressions in liver and islet organoids prior to co‐culture assay. A) Timeline illustrating the differentiation process for liver and islet organoids from hiPSCs. DE, definitive endoderm; HP, hepatic progenitor; HC hepatocyte; PE, pancreatic endoderm; EP, endocrine progenitor; EC, endocrine cell. B) Immunohistochemical staining of hepatic‐specific proteins in liver organoids at day 20, including cytochrome P450 (CYP3A4), hepatocyte (ALB), and cholangiocyte (CK7). Quantification of relative mRNA expression levels of CYP3A4, ALB, and CK7 genes in liver organoids using RT‐PCR. C) The expression of pancreatic‐lineage markers for β‐cells (INS), α‐cells (GCG), γ‐cells (PPY), and δ‐cells (SST) in islet organoids at day 23 were determined by immunofluorescence staining. Quantification of relative mRNA expression levels of INS, GCG, PPY, and SST genes in islet organoids using RT‐PCR. Nuclei were stained with DAPI (blue). Scale bars: 100 µm. Enlarged images indicated by the white squares are shown on the right. Scale bars: 20 µm. Expression values were normalized to GAPDH. Relative expression is represented as the mean ± SEM, three independent experiments were performed. The data were analyzed using Student's t‐test, *p < 0.05, **p < 0.01, and ***p < 0.001.CC BY · PubMed Central
Figure 3 Comparison of cell viability and functionality of liver and islet organoids under mono‐ and co‐culture conditions. A,B) Liver and islet organoids were stained with a live/dead kit on days 5, 15, and 30 during the prolonged culture period. C,D) Examination of albumin secretion by liver organoids and insulin secretion by islet organoids under different culture conditions from days 1 to 40. E) Quantification of relative mRNA expression levels of liver‐specific genes (CYP3A4, ALB, and CK7) and islet‐associated genes (NKX6.1, INS, and GCG) in organoids at day 15 using RT‐PCR in mono‐ and co‐culture groups. Expression values were normalized to GAPDH. Relative expression is represented as the mean ± SEM, three independent experiments were performed. The data were analyzed using Student's t‐test, *p < 0.05, **p < 0.01, and ***p < 0.001. F) Immunohistochemical staining of CYP3A4 (red), ALB (red), and CK7 (green) in liver organoids and NKX6.1 (red), INS (red), and GCG (green) in islet organoids at day 15. DAPI was used to stain the nuclei (blue). Scale bars: 100 µm. Enlarged views are shown below each image. Scale bars: 20 µm.
Figure 3 Comparison of cell viability and functionality of liver and islet organoids under mono‐ and co‐culture conditions. A,B) Liver and islet organoids were stained with a live/dead kit on days 5, 15, and 30 during the prolonged culture period. C,D) Examination of albumin secretion by liver organoids and insulin secretion by islet organoids under different culture conditions from days 1 to 40. E) Quantification of relative mRNA expression levels of liver‐specific genes (CYP3A4, ALB, and CK7) and islet‐associated genes (NKX6.1, INS, and GCG) in organoids at day 15 using RT‐PCR in mono‐ and co‐culture groups. Expression values were normalized to GAPDH. Relative expression is represented as the mean ± SEM, three independent experiments were performed. The data were analyzed using Student's t‐test, *p < 0.05, **p < 0.01, and ***p < 0.001. F) Immunohistochemical staining of CYP3A4 (red), ALB (red), and CK7 (green) in liver organoids and NKX6.1 (red), INS (red), and GCG (green) in islet organoids at day 15. DAPI was used to stain the nuclei (blue). Scale bars: 100 µm. Enlarged views are shown below each image. Scale bars: 20 µm.CC BY · PubMed Central
Figure 4 Transcriptomic analysis of liver and islet organoids in the multi‐organoid‐on‐chip system at day 15. A,B) Volcano plots of the significantly DEGs in liver and islet organoids in co‐cultures compared to mono‐cultures. Genes differentially expressed with fold change over 2.0 and p<0.05 were marked in color. P values were calculated using a two‐sided, unpaired student's t‐test with equal variance assumed (n = 3 independent biological samples). C) Hierarchical clustering heat map for DEGs between mono‐ and co‐cultured liver and islet organoids. Three repeats were performed. The gradient color scale at the right top indicates the log2(fold change) in the expression of the treatment case compared with the control case. D,E) KEGG functional classification of the liver and islet organoid DEGs under mono‐ and co‐culture conditions at day 15. The color of the dots represents the rich factor, while the size represents the input number of genes for each KEGG term. The horizontal axis indicates the significance of enrichment (−log10 (p‐value)). F,G) Validation of selected DEGs identified by RNA‐seq using qRT‐PCR. The expression values were normalized to GAPDH. Data were normalized against mono‐culture expression values and are shown as mean ± SEM, three independent experiments were performed.
Figure 4 Transcriptomic analysis of liver and islet organoids in the multi‐organoid‐on‐chip system at day 15. A,B) Volcano plots of the significantly DEGs in liver and islet organoids in co‐cultures compared to mono‐cultures. Genes differentially expressed with fold change over 2.0 and p<0.05 were marked in color. P values were calculated using a two‐sided, unpaired student's t‐test with equal variance assumed (n = 3 independent biological samples). C) Hierarchical clustering heat map for DEGs between mono‐ and co‐cultured liver and islet organoids. Three repeats were performed. The gradient color scale at the right top indicates the log2(fold change) in the expression of the treatment case compared with the control case. D,E) KEGG functional classification of the liver and islet organoid DEGs under mono‐ and co‐culture conditions at day 15. The color of the dots represents the rich factor, while the size represents the input number of genes for each KEGG term. The horizontal axis indicates the significance of enrichment (−log10 (p‐value)). F,G) Validation of selected DEGs identified by RNA‐seq using qRT‐PCR. The expression values were normalized to GAPDH. Data were normalized against mono‐culture expression values and are shown as mean ± SEM, three independent experiments were performed.CC BY · PubMed Central
Figure 5 Characterization of the interplay between liver and islet organoids in a perfused multi‐organoid chip system. A) Dynamic glucose levels were quantified using a GTT at days 1, 15, and 30 in mono‐ and co‐cultures. Medium containing 11 mm glucose was injected into the mono‐ or co‐culture systems. B) Area under the glucose consumption curve on days 1, 15, and 30. C) Insulin secretion by pancreatic organoids during GTT under different conditions on days 1, 15, and 30. D) Area under the insulin response curve on days 1, 15, and 30. The data were analyzed using Student's t‐test or a one‐way analysis of variance (ANOVA) test and are shown as the mean ± SEM, three independent experiments were performed. *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 5 Characterization of the interplay between liver and islet organoids in a perfused multi‐organoid chip system. A) Dynamic glucose levels were quantified using a GTT at days 1, 15, and 30 in mono‐ and co‐cultures. Medium containing 11 mm glucose was injected into the mono‐ or co‐culture systems. B) Area under the glucose consumption curve on days 1, 15, and 30. C) Insulin secretion by pancreatic organoids during GTT under different conditions on days 1, 15, and 30. D) Area under the insulin response curve on days 1, 15, and 30. The data were analyzed using Student's t‐test or a one‐way analysis of variance (ANOVA) test and are shown as the mean ± SEM, three independent experiments were performed. *p < 0.05, **p < 0.01, and ***p < 0.001.CC BY · PubMed Central
Figure 6 Assessment of mitochondrial function and glucose transport ability in the islet‐liver organoids system in response to hyperglycemia condition and metformin treatment. A,B) Liver and islet organoids were co‐cultured for 15 days and then exposed to three culture conditions (control, 25 mm glucose, and 25 mm glucose with 100 mm metformin). OCR of the liver and islet organoids under these three conditions were measured after 5 days. Oligomycin, FCCP, and rotenone/antimycin A were added at the indicated time points during the experiments, and the data were normalized to cell numbers. C) Immunofluorescence staining of the glucose transport protein marker GLUT1 in islet organoids and GLUT4 in liver organoids in co‐culture under different treatment conditions at day 15. Scale bars: 100 µm. D) Quantitative analysis of relative mRNA expression levels of SLC2A1 in islet organoids and SLC2A4 in liver organoids using RT‐PCR at day 15. The data were analyzed using a one‐way ANOVA with the Bonferroni post‐hoc test and are presented as the mean ± SEM, three independent experiments were performed, *p < 0.05, **p < 0.01, and ***p < 0.001.
Figure 6 Assessment of mitochondrial function and glucose transport ability in the islet‐liver organoids system in response to hyperglycemia condition and metformin treatment. A,B) Liver and islet organoids were co‐cultured for 15 days and then exposed to three culture conditions (control, 25 mm glucose, and 25 mm glucose with 100 mm metformin). OCR of the liver and islet organoids under these three conditions were measured after 5 days. Oligomycin, FCCP, and rotenone/antimycin A were added at the indicated time points during the experiments, and the data were normalized to cell numbers. C) Immunofluorescence staining of the glucose transport protein marker GLUT1 in islet organoids and GLUT4 in liver organoids in co‐culture under different treatment conditions at day 15. Scale bars: 100 µm. D) Quantitative analysis of relative mRNA expression levels of SLC2A1 in islet organoids and SLC2A4 in liver organoids using RT‐PCR at day 15. The data were analyzed using a one‐way ANOVA with the Bonferroni post‐hoc test and are presented as the mean ± SEM, three independent experiments were performed, *p < 0.05, **p < 0.01, and ***p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Research works printed but not linked: 2

  1. 10.1038/s41574-018-0132-z · DOI
  2. Phillips P. J., 2012, Aust. Fam. Physician, 41, 391

Cited by

Metadata

Authors
Tao, T., Deng, P., Wang, Y., Zhang, X., Guo, Y., Chen, W., & Qin, J.
Affiliations
Dalian Institute of Chemical Physics (CN)
Corresponding author
Qin, Jianhua
Venue
Advanced Science
Publisher
Wiley
Published
2021-12-23
Volume
9
Issue
5
Pages
e2103495-e2103495
ISSN
2198-3844 (ISSN-L)
OpenAlex
W4200627985
Cited by
178
References
65
Citations by year
2026: 23 · 2025: 44 · 2024: 60 · 2023: 30 · 2022: 20 · 2021: 1
FWCI
26.07
Type
journal article
Language
en
Open access
Locations
  • Advanced Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Yunnan Key Research and Development Program (202003AD150009)
  • Center for Advanced Study, University of Illinois at Urbana-Champaign (DICP I201934)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
type 2 diabetes, glucose-stimulated insulin secretion, glucose tolerance, mitochondrial dysfunction, glucose transport, metformin, in vitro disease model
MeSH terms
Diabetes Mellitus, Type 2, Humans, Islets of Langerhans, Liver, Organoids, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.